SCHEMBL14920313

SCHEMBL14920313

O=C(O)C1CN(CCF)CCC1c1ccc(Cl)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4589060 0.86 — —
SCHEMBL4589062 0.86 — —
SCHEMBL16108720 0.85 SLC6A2 (0.54) —
SCHEMBL14934559 0.85 SLC6A2 (0.54) —
SCHEMBL16108719 0.85 SLC6A2 (0.54) —
SCHEMBL18771277 0.85 SLC6A2 (0.54) —
SCHEMBL14920711 0.84 PRCP (0.52) —
SCHEMBL14920569 0.84 — —
SCHEMBL16143196 0.83 SLC18A2 (0.54) —
SCHEMBL7084200 0.82 SIGMAR1 (0.48) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2773637-A1 BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS Xenon Pharmaceuticals Inc. (CA) 2014-09-10 — — EP disclosed
WO-2013064983-A1 BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2013-05-10 — — WO disclosed
Send feedback